Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1C | P00326 | 2/20 | 0.48 |
| ▸ | ADH1A | P07327 | 2/20 | 0.48 |
| ▸ | ADH4 | P08319 | 2/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | ADH1B | P00325 | 1/20 | 0.39 |
| ▸ | ADH7 | P40394 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.35 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL388595 | 1.00 | ADH1C (0.48) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL270646 | 1.00 | ADH1C (0.48) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL11337999 | 1.00 | ADH1C (0.48) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL9660235 | 1.00 | ADH1C (0.48) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL303029 | 1.00 | ADH1C (0.48) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL9661097 | 1.00 | ADH1C (0.48) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL9661652 | 1.00 | ADH1C (0.48) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL9660996 | 1.00 | ADH1C (0.48) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL59943 | 0.98 | ADH1C (0.45) | ADH1CADH1AADH4DNM1TSHR | |
| SCHEMBL10934343 | 0.93 | ADH1C (0.47) | ADH1CADH1AADH4DNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050277788-A1 | Process for preparing phthaloyl chloride | LANXESS DEUTSCHLAND GMBH (DE) | 2005-12-15 | — | — | US | claimed |
| EP-1598331-A1 | Process for the preparation of phthalic acid dichloride | Lanxess Deutschland GmbH (DE) | 2005-11-23 | — | — | EP | claimed |
| US-9255070-B2 | Method of deuteration using mixed catalyst | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2016-02-09 | — | — | US | disclosed |
| US-8093422-B2 | Method for deuteration of an aromatic ring | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-01-10 | — | — | US | disclosed |
| US-7517990-B2 | Method for deuteration of a heterocyclic ring | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-14 | — | — | US | disclosed |
| US-20080234488-A1 | Method of Deuteration Using Mixed Catalyst | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2008-09-25 | — | — | US | disclosed |
| US-20070255076-A1 | Method for Deuteration of an Aromatic Ring | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2007-11-01 | — | — | US | disclosed |
| US-7154003-B2 | Process for preparing phthaloyl chloride | LANXESS DEUTSCHLAND GMBH (DE) | 2006-12-26 | — | — | US | disclosed |
| EP-1707548-A1 | METHOD OF DEUTERATION USING MIXED CATALYST | Wako Pure Chemical Industries, Ltd. (JP) | 2006-10-04 | — | — | EP | disclosed |
| US-20060116535-A1 | Method of deuteration | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2006-06-01 | — | — | US | disclosed |
| US-20060025596-A1 | Method for deuteration or tritiation of heterocyclic ring | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2006-02-02 | — | — | US | disclosed |
| US-20050277788-A1 | Process for preparing phthaloyl chloride | LANXESS DEUTSCHLAND GMBH (DE) | 2005-12-15 | — | — | US | disclosed |
| EP-1598331-A1 | Process for the preparation of phthalic acid dichloride | Lanxess Deutschland GmbH (DE) | 2005-11-23 | — | — | EP | disclosed |
| EP-1577280-A1 | METHOD OF DEUTERIZATION | Wako Pure Chemical Industries, Ltd. (JP) | 2005-09-21 | — | — | EP | disclosed |
| EP-1561741-A1 | METHOD FOR DEUTERATION OR TRITIATION OF HETEROCYCLIC RING | Wako Pure Chemical Industries, Ltd. (JP) | 2005-08-10 | — | — | EP | disclosed |
| EP-1535889-A1 | METHOD OF DEUTERATING AROMATIC RING | Wako Pure Chemical Industries, Ltd. (JP) | 2005-06-01 | — | — | EP | disclosed |
| EP-0517262-A1 | Trifluorothymidine derivatives, process for producing the same and anti-cancer agent containing the same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1992-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050277788-A1 | Process for preparing phthaloyl chloride | PHYKPL, PFAS, PGLS | ADH1C 2554/4885ADH1A 3390/4885ADH4 3095/4885 |
| US-20060025596-A1 | Method for deuteration or tritiation of heterocyclic ring | HRH2, HRH4, HDHD5 | ADH1C 715/4885ADH1A 960/4885ADH4 111/4885 |
| US-20080234488-A1 | Method of Deuteration Using Mixed Catalyst | HDHD5, DHX35, HRH3 | ADH1C 1044/4885ADH1A 1333/4885ADH4 164/4885 |
| US-20070255076-A1 | Method for Deuteration of an Aromatic Ring | HRH3, HRH4, AHR | ADH1C 1127/4885ADH1A 823/4885ADH4 145/4885 |
| US-20060116535-A1 | Method of deuteration | ARL1, IDH2, IDH3A | ADH1C 186/4885ADH1A 302/4885ADH4 360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.